A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy
PHASE3
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
PHASE3
The purpose of this extension study is to evaluate maintenance of Hidradeni...